Drug Eluting Stent (DES)
Sponsors
San Giuseppe Moscati Hospital, Biotronik France, Xiongjing Jiang, Deutsches Herzzentrum Muenchen, Fundación EPIC
Conditions
Acute Myocardial InfarctionCoronary Artery DiseaseCoronary Artery DiseasesIschemic StrokeRestenoses, CoronaryVertebral Artery Stenosis
Phase 2
Drug Eluting Stent (DES) in Primary Angioplasty
CompletedNCT00759850
Start: 2003-10-31End: 2007-12-31Updated: 2008-09-25
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
CompletedNCT03201432
Start: 2014-05-31End: 2017-01-31Updated: 2017-06-28
Unknown Phase
BIOTRONIK - BIOFLOW-III Registry French Satellite
NCT02273648
Start: 2014-11-19End: 2021-09-30Updated: 2017-12-14
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
RecruitingNCT05544864
Start: 2022-09-28End: 2026-09-30Target: 376Updated: 2025-01-06
DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)
RecruitingNCT06448637
Start: 2024-10-23End: 2027-12-01Target: 94Updated: 2026-08-05